Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Safety and Efficacy of the Combination of Nivolumab Plus Ipilimumab in Patients With Melanoma and Asymptomatic or Symptomatic Brain Metastases (CheckMate 204)Neuro-oncology 2021 Apr 21;[EPub Ahead of Print], HA Tawbi, PA Forsyth, FS Hodi, CD Lao, SJ Moschos, O Hamid, MB Atkins, K Lewis, RP Thomas, JA Glaspy, S Jang, AP Algazi, NI Khushalani, MA Postow, AC Pavlick, MS Ernstoff, DA Reardon, I Puzanov, RR Kudchadkar, AA Tarhini, A Sumbul, JI Rizzo, KA Margolin
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.